Alkem Labs Launches Off-The-Shelf Cell Therapy StemOne for Knee Joint Diseases
Alkem Laboratories has announced that its off-the-shelf cell therapy product, StemOne has received regulatory approval from the Drug Controller General of India (DCGI) for its launch in India. Article Summary The product, launched by Alkem Laboratories in collaboration with Stempeutics, is indicated for the treatment of Knee Osteoarthritis, a degenerative disease of the joint. The […]
Bluebird bio Announces FDA Approval of ZYNTEGLO®, the First Gene Therapy for Beta-Thalassemia
Bluebird bio Announces FDA Approval of ZYNTEGLO®, the First Gene Therapy for Beta-Thalassemia Bluebird bio, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved ZYNTEGLO® (betibeglogene autotemcel), also known as beti-cel, a one-time gene therapy custom-designed to treat the underlying genetic cause of beta‑thalassemia in adult and pediatric patients who require […]
Cellipont Unveils Plans for Commercial Cell Therapy Facility in Houston
Cellipont Unveils Plans for Commercial Cell Therapy Facility in Houston Cellipont Bioservices, a cell therapy CDMO has unveiled plans for a 76,000 square foot commercial-ready manufacturing facility for cell therapies and gene-modified cell therapies in The Woodlands, TX. The facility will include state-of-the-art manufacturing, process development, assay development and testing capabilities redundant with Cellipont’s 26,000 […]
Prescient Therapeutics Signs Deal with Thermo Fisher Scientific to Promote Development of OmniCAR Cell Therapy Platform
Prescient Therapeutics Signs Deal with Thermo Fisher Scientific to Promote Development of OmniCAR Cell Therapy Platform Australian biotech Prescient Therapeutics has signed an agreement with US-based pharmaceutical services solutions company Thermo Fisher Scientific to accelerate development and commercialisation of a scalable version of its OmniCAR cell therapy platform. Article Summary OmniCAR is a universal immune […]
RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies
AGC Biologics has announced a new strategic partnership with RoosterBio Inc., supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services. Article Summary The new partnership will create an advanced solution for the development and production of hMSC and exosome therapeutics leveraging RoosterBio’s cell and media products and process development services, […]
Vertex and Verve Therapeutics Collaborate to Discover and Develop an In Vivo Gene Editing Program for Liver Disease
Vertex Pharmaceuticals Incorporated and Verve Therapeutics, Inc. has announced an exclusive, four-year global research collaboration to discover and develop an in vivo gene editing program for a single undisclosed liver disease. Article Summary Under the terms of the collaboration, Verve Therapeutics will advance the discovery, research and certain preclinical development of a novel in vivo […]
Frontera Therapeutics Closes $160 Million Series B Funding Round
Frontera Therapeutics, a clinical-stage biotechnology company has announced successful completion of a $160 million Series B funding round to support clinical development and manufacturing capabilities. Article Summary The funding was led by Boyu Capital, Sequoia China, OrbiMed, Creacion Ventures, and other investors. The company also announced that the U.S. Food and Drug Administration (FDA) has […]
Avista Therapeutics Collaborates with Roche to Develop AAV Gene Therapy Vectors for Ocular Diseases
Avista Therapeutics has announced a partnership with Roche to develop novel AAV gene therapy vectors for the eyes. This partnership aims to apply Avista’s single-cell adeno-associated virus (AAV) engineering (scAAVengr) platform technology to develop intravitreal AAV capsids matching a capsid profile defined by Roche. Article Summary Under the terms of the partnership, Roche has the […]
Achilles Therapeutics to lead Horizon Europe-Funded Consortium to Advance Personalized Cell Therapy Manufacturing
Achilles Therapeutics plc, a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, has announced that it is leading a consortium that has been awarded a €4 million ($4.2 million1) grant from Horizon Europe, the European Union’s key funding program for research and innovation. Article Summary The consortium also includes Leibniz University […]
Tessa Therapeutics Closes a US$126 million Series A financing Round
Article Summary Tessa Therapeutics Ltd has announced the close of a US$126 million Series A financing round. The funding was led by Polaris Partners and existing investors, including Temasek, EDBI, Heliconia Capital and Heritas Capital. In conjunction with the financing, Amy Schulman and Darren Carroll, Managing Partners at Polaris Partners, have joined Tessa’s Board of […]
Prescient Therapeutics Unveils its New Cell Therapy Platform – CellPryme-M
A clinical-stage oncology company Prescient Therapeutics (PTX) has launched its second cell therapy platform, CellPryme-M, which produces superior cells with greater cancer killing activity. This platform opens commercial opportunities for the company to incorporate it into third-party manufacturing processes. Article Summary PTX has developed this new platform technology in association with its research partner, Peter […]
Center for Breakthrough Medicines Accelerates Plans to Build the Largest Cell Therapy Manufacturing Operation in the World
The Center for Breakthrough Medicines (CBM) in partnership with the Discovery Labs has accelerated the plans to build capacity to manufacture more than 10,000 patient therapies in direct response to the critical shortage of cell therapy supply, which will help patients win their courageous battles against cancer. Article Summary Planning has begun on a massive […]
